02 July 2004 : Original article
New Perspective on the Management of Hyperlipidemia
Ebrahim A. BalbisiMed Sci Monit 2004; 10(7): LE11-11 :: ID: 16397
Abstract
Dear Editor;
The results of the recently published study by Cannon and colleagues [1] and the previously published Effect of Intensive Compared With Moderate Lipid-Lowering Therapy on Progression of Coronary Atherosclerosis (REVERSAL) [2] provide strong evidence that intensive statin therapy produces superior protection for patients with coronary heart disease and those who have recently had an acute coronary syndrome than does a standard regimen.
Despite previous recommendations which considered an LDL-C level of less than 100 mg per deciliter optimal, [3,4] what is emerging is that the level of reduction is what influences clinical outcomes irrespective of plasma lipid levels. This premise is supported by the findings of The Heart Protection Study,[5] in which the authors concluded that adding a statin regimen to high-risk patients provides substantial benefits irrespective of baseline cholesterol levels. Other effects of statins, such as reductions in the levels of C-reactive protein (CRP) may potentially be viewed as clinical markers for the beneficial effects of statins. However, additional studies are needed to establish the effects of statins on biologic inflammatory markers.
In light of forgoing uncertainties, what is an optimal LDLC level? I would attempt to maintain high-risk patients on intensive lipid-lowering regimen to achieve an LDL-C level below the current recommendations (~70 mg/dl), providing that such level could be achieved safely.
REFERENCES:
1. Cannon CP, Braunwald E, McCabe CH et al: Comparison of Intensive and Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. N Engl J Med, 2004; 350(15): 1495–504
2. Nissen SE, Tuzcu EM, Schoenhagen P et al: JAMA; 291(9): 1071–80
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel
on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA, 2001; 285(19): 2486–97
4. De Backer G, Ambrosioni E, Borch-Johnsen K et al: European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis, 2003; 171: 145–55
5. The Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet, 2002; 360: 7–22
Keywords: Cholesterol, HDL - blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage, Hyperlipidemias - blood, Hyperlipidemias - drug therapy, Cholesterol, HDL - blood, Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage, Hyperlipidemias - drug therapy
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
17 Mar 2024 : Clinical Research
Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...Med Sci Monit In Press; DOI: 10.12659/MSM.942667
27 Mar 2024 : Clinical Research
Impact of Patient Education Formats on Treatment Adherence and Denture Hygiene in Edentulous Patients: A Co...Med Sci Monit In Press; DOI: 10.12659/MSM.944175
27 Mar 2024 : Clinical Research
Incidence, Risk Factors, and Outcomes of Left Atrial Enlargement in Patients Requiring Right Ventricular Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.944114
15 May 2024 : Database Analysis
MRTO4 Enhances Glycolysis to Facilitate HCC Progression by Inhibiting ALDOBMed Sci Monit In Press; DOI: 10.12659/MSM.944685
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952